These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23546403)

  • 41. [Emergent strains of rifampicin-resistant Mycobacterium tuberculosis complex and susceptibility to isoniazid].
    Cacho-Calvo J; Martín-Díaz A;
    Enferm Infecc Microbiol Clin; 2013; 31(7):486-7. PubMed ID: 23623580
    [No Abstract]   [Full Text] [Related]  

  • 42. Analysis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis isolates in Morocco using GenoType
    Ennassiri W; Jaouhari S; Sabouni R; Cherki W; Charof R; Filali-Maltouf A; Lahlou O
    J Glob Antimicrob Resist; 2018 Mar; 12():197-201. PubMed ID: 28993300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new Multi-PCR-SSCP assay for simultaneous detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis.
    Cheng X; Zhang J; Yang L; Xu X; Liu J; Yu W; Su M; Hao X
    J Microbiol Methods; 2007 Aug; 70(2):301-5. PubMed ID: 17543399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic diversity of Mycobacterium tuberculosis and transmission associated with first-line drug resistance: a first analysis in Jalisco, Mexico.
    Lopez-Avalos G; Gonzalez-Palomar G; Lopez-Rodriguez M; Vazquez-Chacon CA; Mora-Aguilera G; Gonzalez-Barrios JA; Villanueva-Arias JC; Sandoval-Diaz M; Miranda-Hernández U; Alvarez-Maya I
    J Glob Antimicrob Resist; 2017 Dec; 11():90-97. PubMed ID: 28760681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
    Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical data and molecular analysis of Mycobacterium tuberculosis isolates from drug-resistant tuberculosis patients in Goiás, Brazil.
    Alves SL; Metzker FS; Araújo-Filho JA; Junqueira-Kipnis AP; Kipnis A
    Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):655-61. PubMed ID: 22012218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system].
    Isakova ZhT
    Georgian Med News; 2008 May; (158):15-9. PubMed ID: 18560033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of a mini-sequencing test, followed by the MALDI-TOF mass-spectrometric analysis to evaluate rifampicin and izoniazid resistance in Mycobacterium tuberculosis circulating in the Russian Federation].
    Afanas'ev MV; Ikriannikova LN; Il'ina EN; Smirnova TG; Larionova EE; Kuz'min AV; Chernousova LN; Kamaev EIu; Skorniakov SN; Kinsht VN; Cherednichenko AG; Govorun VM
    Probl Tuberk Bolezn Legk; 2007; (7):37-42. PubMed ID: 17722291
    [No Abstract]   [Full Text] [Related]  

  • 49. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
    Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Nimri L; Samara H; Batchoun R
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):321-7. PubMed ID: 21569121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.
    Hillemann D; Weizenegger M; Kubica T; Richter E; Niemann S
    J Clin Microbiol; 2005 Aug; 43(8):3699-703. PubMed ID: 16081898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan.
    Hillemann D; Kubica T; Agzamova R; Venera B; Rüsch-Gerdes S; Niemann S
    Int J Tuberc Lung Dis; 2005 Oct; 9(10):1161-7. PubMed ID: 16229229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid detection of rifampicin, isoniazid and streptomycin resistance in Mycobacterium tuberculosis clinical isolates by high-resolution melting curve analysis.
    Yadav R; Sethi S; Mewara A; Dhatwalia SK; Gupta D; Sharma M
    J Appl Microbiol; 2012 Oct; 113(4):856-62. PubMed ID: 22747769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multidrug-resistant and heteroresistant Mycobacterium tuberculosis and associated gene mutations in Ethiopia.
    Mekonnen D; Admassu A; Mulu W; Amor A; Benito A; Gelaye W; Biadglegne F; Abera B
    Int J Infect Dis; 2015 Oct; 39():34-8. PubMed ID: 26119857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis strains by single-strand conformation polymorphism analysis and restriction fragment length polymorphism.
    Piana A; Orrù M; Masia MD; Sotgiu G; Muresu E; Maida A
    New Microbiol; 2003 Oct; 26(4):375-81. PubMed ID: 14596348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular analysis of isoniazid, rifampin and streptomycin resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Düzce, Turkey.
    Ozturk CE; Sanic A; Kaya D; Ceyhan I
    Jpn J Infect Dis; 2005 Oct; 58(5):309-12. PubMed ID: 16249627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis.
    Gryadunov D; Mikhailovich V; Lapa S; Roudinskii N; Donnikov M; Pan'kov S; Markova O; Kuz'min A; Chernousova L; Skotnikova O; Moroz A; Zasedatelev A; Mirzabekov A
    Clin Microbiol Infect; 2005 Jul; 11(7):531-9. PubMed ID: 15966970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes.
    Espasa M; González-Martín J; Alcaide F; Aragón LM; Lonca J; Manterola JM; Salvadó M; Tudó G; Orús P; Coll P
    J Antimicrob Chemother; 2005 Jun; 55(6):860-5. PubMed ID: 15879493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern Ukraine.
    Nikolayevskyy VV; Brown TJ; Bazhora YI; Asmolov AA; Balabanova YM; Drobniewski FA
    Clin Microbiol Infect; 2007 Feb; 13(2):129-138. PubMed ID: 17328724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The GenoType® MTBDRplus assay for detection of drug resistance in Mycobacterium tuberculosis in Sweden.
    Chryssanthou E; Angeby K
    APMIS; 2012 May; 120(5):405-9. PubMed ID: 22515295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.